Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.882
|
Successful |
Myo7aHdb
|
WTSI
|
Fasted Clinical Chemistry / Glycerol
|
HOM
|
12f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.393
|
Successful |
Myo7aHdb
|
WTSI
|
Fasted Clinical Chemistry / LDL-cholesterol
|
HOM
|
12f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.129
|
Successful |
Myo7aHdb
|
WTSI
|
Fasted Clinical Chemistry / HDL-cholesterol
|
HOM
|
12f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.697
|
Successful |
Myo7aHdb
|
WTSI
|
Fasted Clinical Chemistry / Free fatty acids
|
HOM
|
12f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.420
|
Successful |
Myo7aHdb
|
WTSI
|
Fasted Clinical Chemistry / Triglycerides
|
HOM
|
12f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.00259
|
Successful |
Myo7aHdb
|
WTSI
|
Fasted Clinical Chemistry / Total cholesterol
|
HOM
|
12f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0778
|
Successful |
Myo7aHdb
|
WTSI
|
Fasted Clinical Chemistry / Glucose
|
HOM
|
12f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.345
|
Successful |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.938
|
Successful |
Myo7aHdb
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
11f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.867
|
Successful |
Myo7aHdb
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
11f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0800
|
Successful |
Myo7aHdb
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
11f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.846
|
Successful |
Myo7aHdb
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
11f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.000355
|
Successful |
Myo7aHdb
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
11f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.357
|
Successful |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.607
|
Successful |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0764
|
Successful |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0567
|
Successful |
Myo7ash1-6J
|
WTSI
|
Indirect Calorimetry / Heat Production (Metabolic Rate)
|
HET
|
120f:436m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Indirect Calorimetry / Heat Production (Metabolic Rate)
|
HOM
|
60f:436m
|
|
|
NotProcessed |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.975
|
Successful |
Myo7ash1-6J
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
60f:436m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HET
|
120f:436m
|
|
|
NotProcessed |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0355
|
Successful |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.856
|
Successful |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Chloride
|
HET
|
8f:8m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Potassium
|
HET
|
8f:8m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Sodium
|
HET
|
8f:8m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Creatinine
|
HET
|
8f:8m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Urea
|
HET
|
8f:8m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Glucose
|
HET
|
8f:8m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.360
|
Successful |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Calcium
|
HET
|
8f:8m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Albumin
|
HET
|
8f:8m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Total protein
|
HET
|
8f:8m
|
|
|
NotProcessed |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acids
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0211
|
Successful |
Myo7aHdb
|
WTSI
|
DEXA / Fat mass
|
HOM
|
12f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
6.16×10-16
|
Successful |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.944
|
Successful |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0269
|
Successful |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.716
|
Successful |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0748
|
Successful |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
7f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.630
|
Successful |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.533
|
Successful |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Thyroxine
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.738
|
Successful |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HOM
|
f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.845
|
Successful |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Carbon dioxide production
|
HOM
|
f:132m
|
|
|
NotProcessed |
Myo7aHdb
|
WTSI
|
Simplified IPGTT / Glucose response AUC
|
HOM
|
12f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.134
|
Successful |
Myo7ash1-6J
|
WTSI
|
Indirect Calorimetry / Cumulative food intake
|
HET
|
120f:436m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Indirect Calorimetry / Cumulative food intake
|
HOM
|
f:436m
|
|
|
NotProcessed |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglycerides
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.399
|
Successful |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
9.22×10-05
|
Successful |
Myo7aHdb
|
WTSI
|
Simplified IPGTT / Blood glucose concentration
|
HOM
|
60f:45m
|
|
|
NotProcessed |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.586
|
Successful |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0128
|
Successful |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.192
|
Successful |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00719
|
Successful |
Myo7ash1-6J
|
WTSI
|
IPGTT / Blood glucose concentration
|
HOM
|
40f:35m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
IPGTT / Blood glucose concentration
|
HET
|
40f:40m
|
|
|
NotProcessed |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.146
|
Successful |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.701
|
Successful |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.135
|
Successful |
Myo7aHdb
|
WTSI
|
DEXA / Fat/Body weight
|
HOM
|
12f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
2.07×10-13
|
Successful |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HOM
|
f:132m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HET
|
8f:8m
|
|
|
NotProcessed |
Myo7aHdb
|
WTSI
|
Calorimetry / Carbon dioxide production
|
HOM
|
896f:651m
|
|
|
NotProcessed |
Myo7aHdb
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
11f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.777
|
Successful |
Myo7aHdb
|
WTSI
|
Calorimetry / Oxygen consumption
|
HOM
|
896f:651m
|
|
|
NotProcessed |
Myo7aHdb
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
11f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.322
|
Successful |
Myo7aHdb
|
WTSI
|
Calorimetry / Heat production (metabolic rate)
|
HOM
|
896f:651m
|
|
|
NotProcessed |
Myo7aHdb
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
11f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.00327
|
Successful |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.235
|
Successful |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HET
|
8f:8m
|
|
|
NotProcessed |
Myo7aHdb
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
11f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.692
|
Successful |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HET
|
8f:8m
|
|
|
NotProcessed |
Myo7aHdb
|
WTSI
|
Clinical Chemistry / Uric acid
|
HOM
|
11f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.349
|
Successful |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
8f:8m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
8.21×10-06
|
Successful |
Myo7aHdb
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
11f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.961
|
Successful |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
8f:8m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Myo7aHdb
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
11f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.974
|
Successful |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
8f:8m
|
|
|
NotProcessed |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.207
|
Successful |
Myo7aHdb
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
11f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.341
|
Successful |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
8f:8m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Iron
|
HET
|
8f:8m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HET
|
8f:8m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HET
|
8f:8m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
f:132m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Dexa-scan analysis / Fat Mass
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Dexa-scan analysis / Fat Mass
|
HET
|
8f:8m
|
|
|
NotProcessed |
Myo7aHdb
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
11f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.246
|
Successful |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Magnesium
|
HET
|
8f:8m
|
|
|
NotProcessed |
Myo7aHdb
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
11f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.225
|
Successful |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.499
|
Successful |
Myo7aHdb
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
11f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.195
|
Successful |
Myo7aHdb
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
11f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0524
|
Successful |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0197
|
Successful |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Insulin Blood Level / Insulin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.196
|
Successful |
Myo7aHdb
|
WTSI
|
Calorimetry / Cumulative food intake
|
HOM
|
821f:651m
|
|
|
NotProcessed |
Myo7atm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
35f:35m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
5f:5m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HET
|
5f:4m
|
|
|
NotProcessed |
Myo7aHdb
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HOM
|
11f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.194
|
Successful |
Myo7aHdb
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
11f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00118
|
Successful |
Myo7aHdb
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
11f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.000203
|
Successful |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HET
|
8f:8m
|
|
|
NotProcessed |
Myo7aHdb
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
11f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.588
|
Successful |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
8f:8m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Myo7aHdb
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
11f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.601
|
Successful |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HET
|
8f:8m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Myo7aHdb
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
11f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.261
|
Successful |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Uric acid
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Uric acid
|
HET
|
8f:8m
|
|
|
NotProcessed |
Myo7aHdb
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
11f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.775
|
Successful |
Myo7ash1-6J
|
WTSI
|
Dysmorphology / Body fat distribution
|
HET
|
8f:8m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Dysmorphology / Body fat distribution
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Myo7ash1-6J
|
WTSI
|
Clinical Chemistry / Glycerol
|
HET
|
8f:8m
|
|
|
NotProcessed |